Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Uganda

Quality Chemicals Must Compete On Level Playing Field

June 2008 | Company News Alert

The main sources of funding for Uganda's HIV/AIDS treatment programme, the Global Fund To Fight AIDS, Tuberculosis and Malaria and the US President's Emergency Plan for AIDS Relief (PEPFAR) have reiterated that they will not buy antiretroviral (ARV) drugs from local manufacturer Quality Chemicals until it meets international manufacturing standards set down by the World Health Organization

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Health Insurance Scheme Delayed

Industry / Uganda In a major U-turn by the government, the roll-out of Uganda's compulsory National Social Health Insurance Scheme (NSHIS) will be delayed until at least July 2009. Originally slated to be launched in...
July 2008
ARV Need Rising, HIV Prevalence Falling

Industry / Uganda There are now 312,000 people in need of antiretroviral therapy (ART) in Uganda according to the Ministry of Health. The number is a significant increase on the last available data from the World Health...
June 2008
Supply Chain Continues To Offer Up Expired Drugs

Industry / Uganda Chaos in Uganda's drug supply chain continues to create a situation whereby out-of-date drugs are being supplied to hospitals and pharmacies. In the latest episode, 14 boxes of expired antiretroviral...
March 2008
Calls For Clinical Trials Laws Gather Pace

Industry / Uganda The latest figures for Uganda's HIV/AIDS epidemic published by the Ministry of Health make for grim reading. Around 7.9% of women and 6% of men are HIV-positive. Alongside public concerns that the epidemic...
October 2007
Chloroquine Out Of Favour As Resistance Grows

Industry / Uganda Uganda's National Drug Authority is to ban imports of anti-malarial drug chloroqine unless special permission is granted, following the publication of research showing the drug now proves ineffective...
October 2007
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS